Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Phillips

Showing results (941-950 of 976) with videos related to

Pageof 98
Sort By:
Lancet (London, England)|September 14, 2015
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialSheena McCormack, David T Dunn, Monica Desai, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Trials|September 2, 2025
"SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trialVasiliki Papageorgiou, Fiona C Lampe, Janey Sewell, et al.
Journal of the International AIDS Society|July 10, 2019
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysisAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
JMIR Research Protocols|April 20, 2016
A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant CharacteristicsJaney Sewell, Andrew Speakman, Andrew N Phillips, et al.
Proteins|March 25, 2005
Comparison of cell-based and cell-free protocols for producing target proteins from the Arabidopsis thaliana genome for structural studiesRobert C Tyler, David J Aceti, Craig A Bingman, et al.
Nature Communications|September 7, 2023
Heterogeneity in M. tuberculosis β-lactamase inhibition by SulbactamTek Narsingh Malla, Kara Zielinski, Luis Aldama, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2019
Photoreversible interconversion of a phytochrome photosensory module in the crystalline stateE Sethe Burgie, Jonathan A Clinger, Mitchell D Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 98

Showing results (941-950 of 976) with videos related to

Sort By:
Pageof 98
Lancet (London, England)|September 14, 2015
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialSheena McCormack, David T Dunn, Monica Desai, et al.
The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
Trials|September 2, 2025
"SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trialVasiliki Papageorgiou, Fiona C Lampe, Janey Sewell, et al.
Journal of the International AIDS Society|July 10, 2019
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysisAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.
JMIR Research Protocols|April 20, 2016
A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant CharacteristicsJaney Sewell, Andrew Speakman, Andrew N Phillips, et al.
Proteins|March 25, 2005
Comparison of cell-based and cell-free protocols for producing target proteins from the Arabidopsis thaliana genome for structural studiesRobert C Tyler, David J Aceti, Craig A Bingman, et al.
Nature Communications|September 7, 2023
Heterogeneity in M. tuberculosis β-lactamase inhibition by SulbactamTek Narsingh Malla, Kara Zielinski, Luis Aldama, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2019
Photoreversible interconversion of a phytochrome photosensory module in the crystalline stateE Sethe Burgie, Jonathan A Clinger, Mitchell D Miller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Pageof 98